eResearch Issues Stock Potentials Report on BioSyent Inc.

Publishing & Media

Share Tweet

eResearch Issues Stock Potentials Report on BioSyent Inc.

Toronto, ON / ACCESSWIRE / July 3, 2014 / eResearch Corporation provides Stock Potentials reports to highlight interesting prospects which may benefit from the exposure that eResearch can provide through its extensive electronic distribution network. This latest report features BioSyent Inc., a growth-oriented specialty pharmaceutical company, based in Toronto.

BioSyent is a rapidly-growing and profitable independent Canadian pharmaceutical company. Over the past four years, sales have grown from $1.7 million to $7.8 million, and earnings have risen from $48,000 to $1.9 million. The Company's Pharma operations acquire the exclusive Canadian rights to successful international pharmaceutical products which are not available to the Canadian market. It then manages the products through the Canadian governmental regulatory approval process, subsequently marketing them across Canada. The Company also has a small Insecticide business, which manufactures and markets a bio-friendly product used in the protection of stored grain.

Read more in the Stock Potentials report here:  BioSyent Inc.

eResearch is a primary source for professional investment research, focused on small- and mid-cap companies. Our research and analysis is of institutional quality, and has the potential for reaching millions of global investors through our extensive electronic distribution network.

eResearch posts all its reports and articles on its website,, and subscription is FREE.

eResearch: Bob Weir, CFA
Director of Research
E-mail: [email protected]


SOURCE: eResearch Corporation